569 results
Page 4 of 29
8-K
EX-99.1
d0eryzp7it rdd9iar
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
aef9y9w6tcx6
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-3.1
ili88ltl p7
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-99.1
rya10 bii
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
r7yrbm5bu4lapmr bk3t
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
b5wu 7umc
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
3veg4jnkw6gj6a
11 Sep 20
Third party tender offer statement (amended)
6:07am
8-K
EX-10.2
o9t xawp0o1vo8x
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.4
70izrzxn6eb
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
p3j8hl20 29g1
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
7z9zbr
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
baeqk jm0a
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
1jekj 59rooa
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-2.1
lnnlusbxmwpjoeajj
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
vjr6hazw
10 Aug 20
Tender and Support Agreement
9:48pm